Evidence map›Paper›PMID 39801602›Full record

ArticleEuropean heart journal open2025

Corticosteroid therapy and long-term outcomes in patients with cardiac sarcoidosis stratified by left ventricular ejection fraction.

Takatsugu Segawa, Tatsunori Taniguchi, Takeru Nabeta, Yoshihisa Naruse, Takeshi Kitai, Kenji Yoshioka, Hidekazu Tanaka, Takahiro Okumura, Yuichi Baba, Yuya Matsue and 1 more

Abstract read
In one paragraph

Article in European heart journal open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Diagnostic and prognostic value of T2 mapping in cardiac sarcoidosis.International journal of cardiology. Heart & vasculature · 2026
    Article
  2. Article
  3. Redefining Cardiac Sarcoidosis with Advanced Imaging and Therapeutic Strategies.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Takatsugu SegawaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Osaka 565-0871, Japan.
Tatsunori TaniguchiDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Osaka 565-0871, Japan.ORCID https://orcid.org/0009-0004-3434-5864
Takeru NabetaDepartment of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1, Kitazato, Minami-ku, Sagamihara 252-0374, Japan.ORCID https://orcid.org/0000-0003-4671-7667
Yoshihisa NaruseDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 20-1 Handayama, Chuo-ku, Hamamatsu, Japan.ORCID https://orcid.org/0000-0001-9630-951X
Takeshi KitaiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565, Japan.
Kenji YoshiokaDepartment of Cardiology, Kameda Medical Center, 929 Higashi-cho, Chiba 296-8602, Japan.
Hidekazu TanakaDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-Cho, Chuo-Ku, Kobe 650-0017, Japan.ORCID https://orcid.org/0000-0002-1642-7039
Takahiro OkumuraDepartment of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8560, Japan.ORCID https://orcid.org/0000-0001-5076-2052
Yuichi BabaDepartment of Cardiology and Geriatrics, Kochi Medical School, Kochi University, 185-1 Kohasu, Oko-cho, Nankoku 783-8505, Japan.ORCID https://orcid.org/0000-0003-2616-0443
Yuya MatsueDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.ORCID https://orcid.org/0000-0003-2456-8525
Yasushi SakataDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Osaka 565-0871, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: This study aimed to investigate the relationship between corticosteroid therapy and long-term outcomes in patients with cardiac sarcoidosis, stratified by left ventricular ejection fraction (LVEF) at diagnosis. Methods and results: This study conducted a Conclusion: In this large cohort of cardiac sarcoidosis, corticosteroid therapy was associated with a lower incidence of long-term outcomes only in patients with preserved LVEF at diagnosis. Clinical Trial Registration: UMIN000034974.

Indexed as

Cardiac sarcoidosisCorticosteroidLeft ventricular ejection fractionPrognosis

Identifiers

PMID39801602
PMCPMC11720171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.